Directory
>
Yvette Leung
Yvette Leung
VP, Head Of Corporate Development | Dyno Therapeutics
United States
Yvette Leung
Summary
Yvette Leung is an accomplished executive in the biotech sector, currently serving as VP and Head of Corporate Development at Dyno Therapeutics. With a strong background in biomedical sciences and business development, she has a proven track record in launching innovative therapies and driving organizational growth. Yvette has successfully closed major collaborations, including a significant gene delivery partnership valued at $1.6 billion. Her leadership style emphasizes cross-functional influence and team cultivation, which has led to numerous accolades, including the US Hematology Award for Outstanding Performance. Yvette's academic credentials include an MBA from The Wharton School and a cum laude degree from Harvard University in Chemical and Physical Biology. She is also a published researcher, contributing to advancements in malaria and genetics. Outside of her corporate achievements, Yvette is passionate about leveraging technology in healthcare and is committed to improving patient outcomes through strategic innovation.
Yvette Leung
Work Experience
VP, Head Of Corporate Development at
Dyno Therapeutics
October 2021 - Present
US Brand Lead, Hematology Marketing at
Bristol Myers Squibb
November 2019 - September 2021
US Brand Lead, Hematology Marketing (Celgene) at
Bristol Myers Squibb
June 2019 - November 2019
Strategy Consultant (Biopharma) at
Independent Consultant
September 2017 - May 2019
Senior Associate Consultant at
L.E.K. Consulting
January 2014 - January 2017
Researcher - Department of Immunology & Infectious Diseases at
Harvard University
January 2012 - January 2014
Gene Therapy Research Fellow at
McLean Hospital
January 2010 - January 2012
Tuberculosis Research Fellow at
Partners In Health
January 2012 - January 2012
Yvette Leung
Education
Wharton School, Master Of Business Administration - Mba
Harvard University, B.A. Chemical And Physical Biology, Cum Laude
Frequently Asked Questions about Yvette Leung
What is Yvette Leung email address?
Yvette Leung's primary email address is ************@dynotx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Yvette Leung work for?
Yvette Leung is a VP, Head Of Corporate Development at Dyno Therapeutics, a company specializing in Commercial physical research.
Where Yvette Leung graduated from?
Yvette Leung holds a degree in Health Care Management from Wharton School.
How can I directly contact Yvette Leung?
To contact Yvette Leung directly, you can use the email address ************@dynotx.com. Complete contact information is available upon registration with Muraena.
Is Yvette Leung an immigrant?
Yes, Yvette Leung is an immigrant and currently based in United States
Who is Yvette Leung?
Yvette Leung is an accomplished executive in the biotech sector, currently serving as VP and Head of Corporate Development at Dyno Therapeutics. With a strong background in biomedical sciences and business development, she has a proven track record in launching innovative therapies and driving organizational growth. Yvette has successfully closed major collaborations, including a significant gene delivery partnership valued at $1.6 billion. Her leadership style emphasizes cross-functional influence and team cultivation, which has led to numerous accolades, including the US Hematology Award for Outstanding Performance. Yvette's academic credentials include an MBA from The Wharton School and a cum laude degree from Harvard University in Chemical and Physical Biology. She is also a published researcher, contributing to advancements in malaria and genetics. Outside of her corporate achievements, Yvette is passionate about leveraging technology in healthcare and is committed to improving patient outcomes through strategic innovation.
Yvette`s contact details
************@dynotx.com
*******@lek.com
Colleagues
VP, Head of People
VP, Head of Machine Learning
Founder & CEO
VP, Head of Finance
Professor of Neuroscience
Chief Scientific Officer (CSO)